Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	455.24	468.13	480.89	375.69	394.91	329.02
Other Revenue	0.57	0.57	2.95	5.16	2.9	4.07
Revenue	455.81	468.7	483.84	380.84	397.81	333.09
Revenue Growth (YoY)	-0.76%	-3.13%	27.05%	-4.26%	19.43%	-9.92%
Cost of Revenue	190.96	196.94	208.34	160.6	178.89	139.21
Gross Profit	264.85	271.75	275.5	220.24	218.92	193.88
Selling, General & Admin	92.94	92.63	84.26	81.84	76.15	56.91
Research & Development	77.43	79.63	77.07	77.88	72.29	55.64
Other Operating Expenses	-4.76	-2.68	-3.43	-4.3	-2.49	-2.01
Operating Expenses	166.57	171.29	161.48	154.02	146.68	111.67
Operating Income	98.28	100.47	114.02	66.22	72.24	82.21
Interest Expense	-0.26	-0.38	-0.36	-0.11	-0.07	-
Interest & Investment Income	37	37.32	29.6	16.43	19.59	27.82
Currency Exchange Gain (Loss)	10.48	10.48	5.49	26.13	-6.02	-8.54
Other Non Operating Income (Expenses)	-3.63	-0.63	-0.38	-0.38	-0.37	-0.27
EBT Excluding Unusual Items	141.87	147.26	148.36	108.29	85.37	101.22
Gain (Loss) on Sale of Investments	-0.18	0.17	2.93	-1.37	0.43	-
Gain (Loss) on Sale of Assets	5.61	4.61	2.96	-0.5	30.26	0.01
Asset Writedown	-0.47	-	-	-0.51	-1.59	-
Other Unusual Items	4.68	4.8	7.94	9.22	10.08	10.28
Pretax Income	151.51	156.85	162.19	115.13	124.54	111.51
Income Tax Expense	14.93	16.34	15.71	9.29	12.07	11.88
Net Income	136.58	140.51	146.48	105.84	112.47	99.64
Net Income to Common	136.58	140.51	146.48	105.84	112.47	99.64
Net Income Growth	-2.10%	-4.08%	38.40%	-5.89%	12.88%	-5.23%
Shares Outstanding (Basic)	112	112	110	113	112	112
Shares Outstanding (Diluted)	112	112	110	113	112	112
Shares Change (YoY)	1.72%	1.25%	-2.19%	0.11%	0.79%	28.88%
EPS (Basic)	1.22	1.26	1.33	0.94	1.00	0.89
EPS (Diluted)	1.22	1.26	1.33	0.94	1.00	0.89
EPS Growth	-3.75%	-5.26%	41.49%	-6.00%	12.00%	-26.47%
Free Cash Flow	126.78	131.83	51.9	11.53	0.78	51.56
Free Cash Flow Per Share	1.13	1.18	0.47	0.10	0.01	0.46
Dividend Per Share	1.000	1.000	0.800	0.700	0.357	0.571
Dividend Growth	25.00%	25.00%	14.29%	96.02%	-37.50%	-20.01%
Gross Margin	58.10%	57.98%	56.94%	57.83%	55.03%	58.21%
Operating Margin	21.56%	21.44%	23.57%	17.39%	18.16%	24.68%
Profit Margin	29.96%	29.98%	30.28%	27.79%	28.27%	29.91%
Free Cash Flow Margin	27.82%	28.13%	10.73%	3.03%	0.19%	15.48%
EBITDA	109.44	111.73	125.68	78.3	81.53	90.4
EBITDA Margin	24.01%	23.84%	25.97%	20.56%	20.50%	27.14%
D&A For EBITDA	11.16	11.26	11.66	12.07	9.29	8.19
EBIT	98.28	100.47	114.02	66.22	72.24	82.21
EBIT Margin	21.56%	21.44%	23.57%	17.39%	18.16%	24.68%
Effective Tax Rate	9.86%	10.42%	9.69%	8.07%	9.69%	10.65%
Revenue as Reported	455.81	468.7	483.84	380.84	397.81	333.09
Advertising Expenses	-	5.27	3.38	2.64	4.1	4.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.